Q4 2019 13F Holders as of 31 Dec 2019
-
Type / Class
-
Equity / Common Shares, No Par Value
-
Shares outstanding
-
374,002,024
-
Total 13F shares
-
217,592,719
-
Share change
-
+16,307,365
-
Total reported value
-
$6,509,428,132
-
Put/Call ratio
-
104%
-
Price per share
-
$29.92
-
Number of holders
-
306
-
Value change
-
+$538,858,010
-
Number of buys
-
134
-
Number of sells
-
158
Institutional Holders of Bausch Health Companies Inc. - Common Shares, No Par Value (BHC) as of Q4 2019
As of 31 Dec 2019,
Bausch Health Companies Inc. - Common Shares, No Par Value (BHC) was held by
306 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
217,592,719 shares.
The largest 10 holders included
FIL Ltd, PAULSON & CO. INC., ValueAct Holdings, L.P., GLENVIEW CAPITAL MANAGEMENT, LLC, RENAISSANCE TECHNOLOGIES LLC, VANGUARD GROUP INC, GOLDENTREE ASSET MANAGEMENT LP, Slate Path Capital LP, BANK OF MONTREAL /CAN/, and Epoch Investment Partners, Inc..
This page lists
307
institutional shareholders reporting positions in this security
for the Q4 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.